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Abstract 
Data was collected from medical journals to assess changes in the nature and prevalence of 
corporate sponsorship. The journals that reviewed were the Journal of the American Medical 
Association (JAMA), the New England Journal of Medicine (NEJM), the British Medical 
Journal (BMJ), and the Lancet. These journals were chosen because of their high impact on 
medical research representing both American and British Medical editorials. It has been shown 
that corporate sponsorship has been associated with bias results (Kjaergard et al 2002). Changes 
in the nature of corporate sponsorship would be linked to changes in economic climate and 
changes in the policies regarding how research is done and published. Data collected from the 
four journals was used to determine several things: Significant changes in corporate sponsorship, 
differences between European and American editorials, and a potential association between 
subject and corporate sponsorship. 
The consequences of temporal trends have a bearing on social policy because a bias in medical 
research affects many large decisions, such as allocation of research funds, what medicines to 
use on a personal level, and what research should be done in the future.  
Similarities and differences were found in this study. American and British Periodicals both 
showed an increase in For-profit sponsorship of Articles. The percentage of corporate 
sponsorship has increased significantly more for the American periodicals. While American 
Periodicals have roughly equal percentages of Private and Public coauthor affiliations, British 
Periodicals show a stark difference. While American Periodicals are more likely to endorse a 
project, the difference is only around 10 percent. 
 
The Problem 
There have been many allegations that corporate sponsorship has biased all fields of research 
through funding. Gathering data on temporal trends in reported medical research could add 
another dimension to the discussion of corporate sponsorship. If corporate sponsorship has taken 
on a major role only recently, then an analysis of changes in policy could be done to see what led 
to this change in funding. If recent changes in policies have led to a bias of research, then 
perhaps those policies should be reevaluated. 
This study aimed to make note of major temporal trends in the corporate sponsorship of 
American and European editorials.  
Background to the Problem 
Questions about the link between the corporate funding of research and a potential bias started 
with suspicions regarding studies funded by the tobacco industry (Turner and Spilich et al 1997). 
Questions about a potential conflict of interest then began to be raised about other subjects. Some 
of the first conversations regarding the need for financial disclosures and the role of potential 
bias came when scandals occurred at noted medical journals such as the NEMJ (Angell and 
Kassirer 1996) and the BMJ (Smith 1998).  
In the following years many papers have been conducted which investigate the potential role of 
corporate sponsorship and bias. Epidemiological studies of randomized clinical trials published 
in various medical journals have shown that there is a distinct correlation between competing 
interests and authors' conclusions (Kjaergard et al 2002). Studies have also been done to 
determine if there is a difference between the methodology of tests funded by pharmaceutical 
companies and those who list no competing interests. Articles were picked by well-defined 
medical article database searches (Lexchin and Bero et al 2003).  
Many papers have been written that investigate the relationship between pharmaceutical 
companies and research. A paper by Resnik and Elliot identified five factors to determine 
whether financial relationships are likely to enhance, undermine, or have no impact on the 
credibility of research (Resnik and Elliot et al 2013). A paper by Wand and Murad offered 
possible suggestions by which industry can potentially exert effects and propose new directions 
for the future (Wand and Murad et al 2010). 
The study I suggest would add to the collection of studies done by looking at a much larger 
timespan, compare and contrast American and European editorials, and gathering more variables 
than previous studies which may offer additional insights. 
Research Design 
The journals that have been chosen for this study were selected based on their high impact on 
medical research. Two journals are American medical journals and two are British medical 
journals. This selection allows for a comparison between American and European editorials. 
From these journals a sampling of each publication year selected will be taken. Two issues from 
a publication year will be selected – the first issue of the year and the first issue in July. From 
these issues, the articles selected for review will be of the following categories: original 
contributions, brief reports, reporting of cases, and laboratory technique notes. Articles that will 
be excluded from the study include: editorials, book reviews, special communications, 
corrections, letters, medical news, or any article that is not the result of data collection. 
A rubric has been designed for this study that will gather the following data: number of 
coauthors, if the article is international, the lead author, the lead author's institute, the lead 
authors type of Institute (Hospital, University, Lab), whether the institute is public or private; the 
last author, the last author's Institute, type of Institute (Hospital, University, Lab, or Government 
Organization), whether the institute is public or private, coauthors collective affiliations; study 
design (Clinical Study, Data Review, Drug Review, Equipment Review, Questionnaire, Report 
of Case) , origin of funding (Public or Private), how funding was described (Grant, Chemicals, or 
Equipment), and study subject, and if the study was in support of the product (Negative, Neutral, 
or Positive). 
Layout of the Rubric described above 
Issue International Number of Coauthors First Author Lead Author's Institute Institute Type Public or Private 
        
Last author Last Author's Institute Institute Type Public or Private Coauthors Affiliations 
      
Study Design Funding How was Funding Defined Study Subject 
Is Subject 
Marketable 
Endorsement of 
Product 
 
 
 
Results 
Figures 1-9 were generated from the data gathered using the rubric and collected in tables 1,2,3, 
and 4 in the appendix. Figures 1-3 focused on the funding of articles. The figures went from 
most general to more specific. Figures 4-6 focused on coauthors affiliations to a public or private 
institute. Yet again the figures go from most general to most specific. Figures 7-9 focused on the 
endorsement or non-endorsement of marketable subjects. The figures went from their most 
general form to most specific. Figures 10 and 11 show the endorsement or lack of endorsement 
of marketable subjects based on type of funding. 
 
 
Figure 1. Pie chart representing the funding of articles from the year 1960-2015. This Pie chart is 
independent of Time or distinction of periodical’s country.  
 Figure 2. Percentage of Articles which have any source of Corporate Sponsorship Independent of 
Time. 
 
 
Figure 3. Percentage of Articles which have any source of Corporate Sponsorship 
 Figure 4. Percentage of Coauthors belonging to a Private or Public Institute from 1960-2015. 
 
Figure 5. Percentage of Coauthors belonging to a Private or Public Institute Independent of Time 
 
 Figure 6. Percentage of Coauthor Affiliations which were Private or a mix of Private and Public.  
 
 
Figure 7. Percentage of marketable subjects that received or didn’t receive Endorsement 
independent of Time or County 
 Figure 8. Percentage of marketable subjects that received or didn’t receive Endorsement 
independent of Time  
 
 
Figure 9. Percentage of marketable subjects that received or didn’t receive Endorsement by the 
study reviewing them.  
 Figure 10. Sum of the endorsement or lack of endorsement of marketable subjects based on type 
of funding for all four periodicals independent of time.  
 
Figure 11. Endorsement or Lack of Endorsement of Marketable Subjects based on Type of 
Funding Independent of Time 
 
Discussion and Conclusion 
As can be seen in Figure 3 two patterns are noticeable. The first trend is that the Percentage of 
Articles which have any source of corporate sponsorship has increased for both the British and 
American periodicals. The second trend is that the increase in the percentage of corporate 
sponsorship has increased significantly more for the American periodicals. Figure 2 shows that 
the types of Funding in American and British Articles were very similar. In fact for For-Profit 
funding, independent of time, the rate was the same. 
Figure 4 shows that while American Periodicals have roughly equal percentages of Private and 
Public coauthor affiliations, British Periodicals show a stark difference. This pattern is expected 
as a majority of British universities and hospitals are publically funded. As can be seen in Figure 
6 the British Periodical does not show a change over the decades in percentage of coauthor 
affiliations which were Private or a mix of Private and Public. Interestingly the American 
Periodicals show a steady decrease, with the exception of the decade of the 2000s, in the 
percentage of coauthor affiliations which were Private or a mix of Private and Public.  
Figure 7 shows that a marketable subject which has an article written about it has a 65.4 percent 
chance to be endorsed. Figure 8 shows that while American Periodicals are more likely to 
endorse a project, the difference is only around 10 percent. Figure 9 shows that American 
Periodicals are more likely to endorse a marketable product which is being reviewed. The reason 
for this difference in percentage could be due to a number of factors such as: higher rates of 
corporate sponsorship, differences in selection of marketable subjects to review, or differences in 
concluding if a subject was successful or not. 
Figures 10 and 11 are the strongest evidence of the biasing role of corporate sponsorship. It is 
clearly shown that any article funded by corporate sponsorship is likely to endorse a marketable 
subject. Additionally Figure 11 shows that American periodicals are more likely to have an 
endorsement of marketable subjects based on if they have a corporate sponsor.  
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